ArticleImmunoHorizons2026
Distinct immunomodulatory effects of synthetic progestins compared with natural progesterone in human immune cells.
Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Progesterone exerts important immunomodulatory functions, yet the immune effects of structurally diverse synthetic progestins remain incompletely defined. Given their variable receptor-binding profiles and links to altered inflammatory outcomes, we examined how commonly used progestins regulate immune signaling in primary human cells. Peripheral blood mononuclear cells from healthy female donors were exposed to physiologically relevant concentrations of natural progesterone (P4) and representative synthetic progestins spanning multiple generations. Cytokine responses were quantified at both the protein and transcript levels. Baseline steroid receptor expression and age of donor was correlated with cytokine output. High-dimensional flow cytometry coupled with unsupervised clustering was used to define the cellular sources of inflammatory cytokine production. In parallel, naïve CD4+ T-cell differentiation was performed to determine effects on T helper (Th) cell polarization. Only P4 induced immunoregulatory cytokine IL-10, whereas all progestins, except first-generation norethindrone, induced markedly higher IL-6 production compared with media control. Gene expression analysis confirmed induction of multiple proinflammatory genes at physiologically relevant concentrations. High-dimensional flow cytometry identified CD14+ monocytes as the dominant cellular source of IL-6 following progestin exposure. In contrast, P4 selectively suppressed Th1 differentiation and promoted Th2 lineage commitment, whereas synthetic progestins failed to reproduce these immunoregulatory effects. Together, these findings demonstrate that synthetic progestins differentially regulate innate and adaptive immune responses compared with P4 and promote proinflammatory responses that may influence immune homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.